These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10218610)

  • 1. Left ventricular assist system support is associated with persistent inflammation and temporary immunosuppression.
    Deng MC; Erren M; Tjan TD; Tamminga N; Werntze B; Zimmermann P; Weyand M; Hammel D; Schmidt C; Scheld HH
    Thorac Cardiovasc Surg; 1999 Feb; 47 Suppl 2():326-31. PubMed ID: 10218610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application.
    McCarthy PM; Portner PM; Tobler HG; Starnes VA; Ramasamy N; Oyer PE
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):578-86; discussion 586-7. PubMed ID: 1921434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation.
    Frazier OH; Rose EA; Oz MC; Dembitsky W; McCarthy P; Radovancevic B; Poirier VL; Dasse KA;
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1186-95. PubMed ID: 11726895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
    Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
    J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal timing of cardiac transplantation after ventricular assist device implantation.
    Gammie JS; Edwards LB; Griffith BP; Pierson RN; Tsao L
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1789-99. PubMed ID: 15173738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA sensitization in ventricular assist device recipients: does type of device make a difference?
    Kumpati GS; Cook DJ; Blackstone EH; Rajeswaran J; Abdo AS; Young JB; Starling RC; Smedira NG; McCarthy PM
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1800-7. PubMed ID: 15173739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device.
    Russell SD; Rogers JG; Milano CA; Dyke DB; Pagani FD; Aranda JM; Klodell CT; Boyle AJ; John R; Chen L; Massey HT; Farrar DJ; Conte JV;
    Circulation; 2009 Dec; 120(23):2352-7. PubMed ID: 19933938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical circulatory support with the Novacor LVAS: world-wide clinical results.
    Murali S
    Thorac Cardiovasc Surg; 1999 Feb; 47 Suppl 2():321-5. PubMed ID: 10218609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.
    Cleveland JC; Grover FL; Fullerton DA; Campbell DN; Mitchell MB; Lindenfeld J; Wolfel EE; Lowes BD; Shakar SF; Brieke A; Cannon A; Robertson AD
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):774-7. PubMed ID: 18805284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric heart transplant candidates with failed donor heart allocation after Eurotransplant urgency listing profit from pretransplant mechanical circulatory support bridging.
    Komoda T; Lehmkuhl HB; Stiller B; Berger F; Hetzer R
    Artif Organs; 2009 Apr; 33(4):346-51. PubMed ID: 19335411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells in ventricular assist device patients.
    Termuhlen DF; Pennington DG; Roodman ST; Ruzevich SA; Swartz MT; Reedy JE; McBride LR; Miller LW; Tsai CC; Kennedy DJ
    Circulation; 1989 Nov; 80(5 Pt 2):III174-82. PubMed ID: 2805299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
    Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
    Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy.
    Hetzer R; Müller JH; Weng YG; Loebe M; Wallukat G
    J Thorac Cardiovasc Surg; 2000 Nov; 120(5):843-53. PubMed ID: 11044309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices.
    Garatti A; Bruschi G; Colombo T; Russo C; Lanfranconi M; Milazzo F; Frigerio M; Vitali E
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):275-80; discussion 280. PubMed ID: 18375138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of left ventricular assist device support affects transplant survival.
    Ashton RC; Goldstein DJ; Rose EA; Weinberg AD; Levin HR; Oz MC
    J Heart Lung Transplant; 1996 Nov; 15(11):1151-7. PubMed ID: 8956124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical versus medical bridge to transplantation in children. What is the best timing for mechanical bridge?
    Reddy SL; Hasan A; Hamilton LR; Dark J; Schueler SW; Bolton DT; Haynes SR; Smith JH
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):605-9. PubMed ID: 15037279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection and outcome of ventricular assist device patients: the Muenster experience.
    Deng MC; Weyand M; Hammel D; Schmid C; Kerber S; Schmidt C; Breithardt G; Scheld HH
    J Heart Lung Transplant; 1998 Aug; 17(8):817-25. PubMed ID: 9730432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eleven years' experience with the Pierce-Donachy ventricular assist device.
    Pennington DG; McBride LR; Miller LW; Swartz MT
    J Heart Lung Transplant; 1994; 13(5):803-10. PubMed ID: 7803421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.